Cue Biopharma, Inc. (CUE)
$19.57-20.48%Close
SELLCRISIS · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $51M
- Beta
- 2.63
- P/E (TTM)
- -0.72
- Short % float
- 26.93%
- Days to cover
- 1.1
- SI change
- +111.4%
- 1W
- -15.43%
- 1M
- -35.94%
- vs SPY 1W
- -15.29%
- vs SPY 1M
- -38.45%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on CUE?
- LOPJLB’s latest quantitative signal on Cue Biopharma, Inc. (CUE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CUE in?
- Cue Biopharma, Inc. (CUE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cue Biopharma, Inc. (CUE) do?
- Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigational therapeutic is CUE-101, a specialized fusion pr…